Metropolis Acquires Kolhapur Lab to Boost Regional Reach

Metropolis Healthcare, a diagnostics company with its headquarters in Mumbai, stated on Thursday that it has paid Rs 17 crore to acquire Ambika Pathology Laboratory, located in Kolhapur.A deferred component of Rs 1.7 crore is included in the consideration; this component is part of the total value and will be paid according to the terms specified in the business transfer agreement (BTA).

This acquisition represents the fourth acquisition by Metropolis in the past ten months in line with its "string-of-pearls" strategy of establishing strong regional clusters, while also expanding access to high-quality diagnostics throughout India.

The company further stated that with this acquisition, it strengthens its leadership position in the Kolhapur region and is strategically focused on establishing a mini reference laboratory that will provide advanced diagnostics to the surrounding four to five districts in the western Maharashtra belt. On Thursday, Mumbai-based diagnostics player Metropolis Healthcare announced that it has acquired Ambika Pathology Laboratory, based in Kolhapur, for a total consideration of INR 17 Crores.

Also Read: Biocon Biologics Gets FDA Approval for Osteoporosis Care

Part of the consideration includes a deferred payment of Rs 1.7 crore, which is part of the total consideration and will be paid as per the terms agreed in the business transfer agreement (BTA). This is Metropolis' fourth acquisition in the last ten months in line with its string-of-pearls strategy focused on building strong regional clusters and enhancing access to advanced diagnostics throughout India.

The company added that this acquisition strengthens Metropolis' leadership in Kolhapur and is strategically targeted at establishing a mini reference laboratory to serve the next four to five districts around the western Maharashtra belt.